![](/img/cover-not-exists.png)
Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a nextâgeneration HIVâ1 maturation inhibitor
Joshi, Samit R., Fernando, Disala, Igwe, Stephanie, McKenzie, Litza, Krishnatry, Anu S., Halliday, Fiona, Zhan, Joyce, Greene, Thomas J., Xu, Jianfeng, FerronâBrady, Geraldine, Lataillade, Max, Min,Volume:
8
Journal:
Pharmacology Research & Perspectives
DOI:
10.1002/prp2.671
Date:
December, 2020
File:
PDF, 1.69 MB
2020